Clinical Trial Update: Indirect Pulp Capping With Resin Modified Glass Ionomer [NA]

View source ↗

Summary

This clinical trial evaluating indirect pulp capping with resin-modified glass ionomer has completed (NCT02494193). Sponsored by Universidade Federal de Sergipe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Pulpitis

Drugs mentioned

• Resin-modified glass ionomer cement (Resin-modified glass ionomer cement)

Snippet

Sponsor: Universidade Federal de Sergipe | Conditions: Caries, Dental, Pulpitis | NA | Status: COMPLETED